Publicaciones en colaboración con investigadores/as de Consorci Sanitari de Terrassa (4)

2024

  1. Mid-trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre-eclampsia: Post-hoc analysis of StopPRE trial

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 131, Núm. 3, pp. 334-342

  2. Placental growth factor at 24–28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial

    Acta Obstetricia et Gynecologica Scandinavica

2023

  1. Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial

    JAMA, Vol. 329, Núm. 7, pp. 542-550

  2. Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial

    Obstetrical and Gynecological Survey